Liberal healthcare advocates have mounted pressure on the Biden administration to approve the Democrats’ controversial plan allowing the government to negotiate drug prices, a multimillion-dollar effort meant to counterattack the pharmaceutical industry.
Appeal by Skipton Building Society Camerata to help it make more music videos while venues remain closed. SKIPTON Building Society Camerata says it wants to put its musicians to work, and so is asking for donations towards the cost of making music videos. It was a year in March since the start of the first coronavirus lockdown that brought an abrupt halt to live concerts. Over the past year, the professional orchestra says it has panned and prepared for a return to the concert hall, several times over, and even now with restrictions starting to ease, there is still a certain amount of uncertainty.
The High Cost of Drug Price Controls
Commentary By
The debate over expanding government control of our health sector should have ended during the COVID-19 pandemic:
Where there have been failures in responding to the crisis, it has been a failure of big government such as the Centers for Disease Control and Prevention’s arrogant and clumsy insistence on controlling early development of testing that delayed the U.S. response and surely cost lives. Or the failure to protect those most at risk, especially seniors in nursing homes. Or CDC’s decades-long refusal to develop a modern data tracking system.
Commentary: Biden shouldn’t disarm pharmaceutical innovation that’s winning war on Covid
Commentary: Doug Badger, The Heritage Foundation
By Doug Badger, The Heritage Foundation, (TNS)
As the Covid-19 vaccines show, pharmaceutical innovation provides the best hope of ending the pandemic. Unfortunately, the Biden administration is launching what amounts to a federal assault against such innovation.
That assault will take the form of federal price controls on prescription medicines. When the House of Representatives attempted to impose such controls in 2019, the White House Council of Economic Advisers said it could result in as many as 100 fewer drugs entering the market over the next decade.
Heritage Scholars Sound off on Biden’s Address to Congress
WASHINGTON, DC - APRIL 28: U.S. President Joe Biden addresses a joint session of congress as Vice President Kamala Harris and Speaker of the House Nancy Pelosi look on in the House chamber of the U.S. Capitol on April 28. (Photo: Chip Somodevilla/Getty Images)
Commentary By
Christian Mysliwiec is commentary editor of The Daily Signal.
President Joe Biden is addressing a joint session of Congress this evening, and experts from The Heritage Foundation are weighing in. Here’s what they have to say. > The Daily Signal is the news and commentary outlet of The Heritage Foundation.